Actinium Pharmaceuticals
ATNM
#9862
Rank
$43.67 M
Marketcap
$1.40
Share price
-2.10%
Change (1 day)
6.06%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -$44.25 Million USD

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$42.13 Million USD, an increase over its 2023 earnings that were of -$51.92 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$44.25 Million5.05%
2024 -$42.13 Million-18.87%
2023 -$51.92 Million52.24%
2022 -$34.11 Million36.61%
2021 -$24.97 Million11.48%
2020 -$22.4 Million1.46%
2019 -$22.08 Million-7.37%
2018 -$23.83 Million-11.46%
2017 -$26.92 Million10.67%
2016 -$24.32 Million15.7%
2015 -$21.02 Million-14.86%
2014 -$24.69 Million129.19%
2013 -$10.78 Million-8.55%
2012 -$11.78 Million
2010 $0 M-152.15%
2009 -$0.02 Million-39.8%
2008 -$0.03 Million120.29%
2007 -$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-$37.2 Million-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.67 B-1,635.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$4.98 M-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA